Natural History of MYH7-Related Dilated Cardiomyopathy
Publication year
2022Author(s)
Source
Journal of the American College of Cardiology, 80, 15, (2022), pp. 1447-1461ISSN
Publication type
Article / Letter to editor

Display more detailsDisplay less details
Organization
Human Genetics
Journal title
Journal of the American College of Cardiology
Volume
vol. 80
Issue
iss. 15
Page start
p. 1447
Page end
p. 1461
Subject
Radboudumc 7: Neurodevelopmental disorders DCMN: Donders Center for Medical NeuroscienceAbstract
BACKGROUND: Variants in myosin heavy chain 7 (MYH7) are responsible for disease in 1% to 5% of patients with dilated cardiomyopathy (DCM); however, the clinical characteristics and natural history of MYH7-related DCM are poorly described. OBJECTIVES: We sought to determine the phenotype and prognosis of MYH7-related DCM. We also evaluated the influence of variant location on phenotypic expression. METHODS: We studied clinical data from 147 individuals with DCM-causing MYH7 variants (47.6% female; 35.6 ± 19.2 years) recruited from 29 international centers. RESULTS: At initial evaluation, 106 (72.1%) patients had DCM (left ventricular ejection fraction: 34.5% ± 11.7%). Median follow-up was 4.5 years (IQR: 1.7-8.0 years), and 23.7% of carriers who were initially phenotype-negative developed DCM. Phenotypic expression by 40 and 60 years was 46% and 88%, respectively, with 18 patients (16%) first diagnosed at <18 years of age. Thirty-six percent of patients with DCM met imaging criteria for LV noncompaction. During follow-up, 28% showed left ventricular reverse remodeling. Incidence of adverse cardiac events among patients with DCM at 5 years was 11.6%, with 5 (4.6%) deaths caused by end-stage heart failure (ESHF) and 5 patients (4.6%) requiring heart transplantation. The major ventricular arrhythmia rate was low (1.0% and 2.1% at 5 years in patients with DCM and in those with LVEF of ≤35%, respectively). ESHF and major ventricular arrhythmia were significantly lower compared with LMNA-related DCM and similar to DCM caused by TTN truncating variants. CONCLUSIONS: MYH7-related DCM is characterized by early age of onset, high phenotypic expression, low left ventricular reverse remodeling, and frequent progression to ESHF. Heart failure complications predominate over ventricular arrhythmias, which are rare.
This item appears in the following Collection(s)
- Academic publications [227613]
- Electronic publications [107286]
- Faculty of Medical Sciences [86193]
- Open Access publications [76413]
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.
Related items
Showing items related by title, author, creator and subject.
-
Outcome of infection with omicron SARS-CoV-2 variant in patients with hematological malignancies: An EPICOVIDEHA survey report
Blennow, O.; Salmanton-García, J.; Nowak, P.; Itri, F.; Doesum, J. Van; López-García, A.; Farina, F.; Jaksic, O.; Pinczés, L.I.; Bilgin, Y.M.; Falces-Romero, I.; Jiménez, M.; Ormazabal-Vélez, I.; Weinbergerová, B.; Duléry, R.; Stojanoski, Z.; Lahmer, T.; Fernández, N.; Hernández-Rivas, J.; Petzer, V.; Jonge, N. de; Glenthøj, A.; Ramón, C. De; Biernat, M.M.; Fracchiolla, N.; Aujayeb, A.; Praet, J. Van; Schönlein, M.; Méndez, G.A.; Cattaneo, C.; Guidetti, A.; Sciumè, M.; Ammatuna, E.; Cordoba, R.; García-Poutón, N.; Gräfe, S.; Cabirta, A.; Wolf, D.; Nordlander, A.; García-Sanz, R.; Delia, M.; Venemyr, C. Berg; Brones, C.; Blasi, R. Di; Kort, E.A. de; Meers, S.; Lamure, S.; Serrano, L.; Merelli, M.; Coppola, N.; Bergantim, R.; Besson, C.; Kohn, M.; Petiti, J.; Garcia-Vidal, C.; Dargenio, M.; Danion, F.; Machado, M.; Bailén-Almorox, R.; Hoenigl, M.; Dragonetti, G.; Chai, L.Y.; Kho, C.S.; Bonanni, M.; Liévin, R.; Marchesi, F.; Cornely, O.A.; Pagano, L.et al.sine al.
2022, Article / Letter to editor (American Journal of Hematology, 97, 8, (2022), pp. E312-e317) -
Influence of the IL6 Gene in Susceptibility to Systemic Sclerosis
Cenit, M.C.; Simeon, C.P.; Vonk, M.C.; Callejas-Rubio, J.L.; Espinosa, G.; Carreira, P.; Blanco, F.J.; Narvaez, J.; Tolosa, C.; Roman-Ivorra, J.A.; Gomez-Garcia, I.; Garcia-Hernandez, F.J.; Gallego, M.; Garcia-Portales, R.; Egurbide, M.V.; Fonollosa, V.; Garcia de la Pena, P.; Lopez-Longo, F.J.; Gonzalez-Gay, M.A.; The Spanish Scleroderma, G.; Hesselstrand, R.; Riemekasten, G.; Witte, T.J.M. de; Voskuyl, A.E.; Schuerwegh, A.J.; Madhok, R.; Fonseca, C.; Denton, C.; Nordin, A.; Palm, O.; Laar, J.M. van; Hunzelmann, N.; Distler, J.H.; Kreuter, A.; Herrick, A.; Worthington, J.; Koeleman, B.P.; Radstake, T.R.D.J.; Martin, J.et al.sine al.
2012, Article / Letter to editor (The Journal of Rheumatology, 39, 12, (2012), pp. 2294-2302) -
Genetics, pathogenesis and therapeutic developments for Usher syndrome type 2
Stemerdink, M.; García-Bohórquez, B.; Schellens, R.T.W.; Garcia-Garcia, G.; WIjk, E. van; Millan, J.M.2022, Article / Letter to editor (Human Genetics, 141, 3-4, (2022), pp. 737-758)